| __timestamp | Halozyme Therapeutics, Inc. | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 74244000000 |
| Thursday, January 1, 2015 | 105812000 | 91739000000 |
| Friday, January 1, 2016 | 113485000 | 94597000000 |
| Sunday, January 1, 2017 | 285461000 | 94064000000 |
| Monday, January 1, 2018 | 141726000 | 94214000000 |
| Tuesday, January 1, 2019 | 150446000 | 101933000000 |
| Wednesday, January 1, 2020 | 224227000 | 106014000000 |
| Friday, January 1, 2021 | 361897000 | 117142000000 |
| Saturday, January 1, 2022 | 520812000 | 148506000000 |
| Sunday, January 1, 2023 | 636892000 | 196496000000 |
| Monday, January 1, 2024 | 855907000 | 245881000000 |
Cracking the code
In the competitive world of pharmaceuticals, Novo Nordisk A/S and Halozyme Therapeutics, Inc. have carved out distinct paths. From 2014 to 2023, Novo Nordisk consistently outperformed Halozyme in gross profit, showcasing its dominance in the industry. In 2023, Novo Nordisk's gross profit was approximately 31 times higher than Halozyme's, highlighting its robust market position. Over the decade, Novo Nordisk's gross profit grew by 165%, while Halozyme saw a remarkable increase of over 1,100%, albeit from a much smaller base. This growth trajectory underscores Halozyme's potential in the market. As the pharmaceutical landscape evolves, these figures provide a snapshot of the strategic maneuvers and market dynamics at play. Investors and industry watchers should keep a keen eye on these trends as they reflect broader shifts in the sector.
Novo Nordisk A/S vs Bristol-Myers Squibb Company: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Novo Nordisk A/S and Regeneron Pharmaceuticals, Inc.
Novo Nordisk A/S vs Halozyme Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Gross Profit Comparison: Novo Nordisk A/S and Jazz Pharmaceuticals plc Trends
Who Generates Higher Gross Profit? Novo Nordisk A/S or Alkermes plc
Who Generates Higher Gross Profit? Novo Nordisk A/S or Amphastar Pharmaceuticals, Inc.
Gross Profit Trends Compared: Novartis AG vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Bio-Techne Corporation and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Ascendis Pharma A/S vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.